CVS Health Corporation logo

CVS Health Corporation (CVS)

Market Open
4 Jun, 14:43
NYSE NYSE
$
93. 89
+2.52
+2.7525%
$
116.08B Market Cap
11.4 P/E Ratio
0.64% Div Yield
3.76M Volume
7.87 Eps
$ 91.37
Previous Close
Add Transaction
Day Range
93.03 94.61
Year Range
58.5 98.43
Want to track CVS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
CVS Health (CVS) Reports Q3 Earnings: What Key Metrics Have to Say

CVS Health (CVS) Reports Q3 Earnings: What Key Metrics Have to Say

The headline numbers for CVS Health (CVS) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks | 7 months ago
CVS Health Corporation (CVS) Q3 2025 Earnings Call Transcript

CVS Health Corporation (CVS) Q3 2025 Earnings Call Transcript

CVS Health Corporation ( CVS ) Q3 2025 Earnings Call October 29, 2025 8:00 AM EDT Company Participants Larry McGrath - Executive VP, Chief Strategy Officer & Chief Strategic Advisor to the CEO J. Joyner - President, CEO & Director Brian Newman - Executive VP & CFO Prem Shah - Executive VP & Group President Steven Nelson - Executive VP & President of Aetna Conference Call Participants Lisa Gill - JPMorgan Chase & Co, Research Division Justin Lake - Wolfe Research, LLC Elizabeth Anderson - Evercore ISI Institutional Equities, Research Division Stephen Baxter - Wells Fargo Securities, LLC, Research Division Michael Cherny - Leerink Partners LLC, Research Division Eric Percher - Nephron Research LLC Andrew Mok - Barclays Bank PLC, Research Division George Hill - Deutsche Bank AG, Research Division Kevin Caliendo - UBS Investment Bank, Research Division Presentation Operator Hello, and welcome to CVS Health's Third Quarter 2025 Earnings Call.

Seekingalpha | 7 months ago
CVS Posts Strong Q3 Earnings, but Shares Show Little Movement

CVS Posts Strong Q3 Earnings, but Shares Show Little Movement

CVS reported Q3 financials showing it beat on earnings and revenue, which resulted in strong forward guidance.

247wallst | 7 months ago
CVS Stock Falls Despite Q3 Earnings & Revenue Beat, '25 EPS View Up

CVS Stock Falls Despite Q3 Earnings & Revenue Beat, '25 EPS View Up

CVS shares slip even though Q3 earnings and revenues beat estimates, with the company boosting its 2025 EPS outlook.

Zacks | 7 months ago
CVS Posts Loss on Write-Down, Boosts Guidance

CVS Posts Loss on Write-Down, Boosts Guidance

CVS Health raised its guidance for the rest of the year, boosted by improved performance at its Aetna insurance unit.

Wsj | 7 months ago
CVS Health (CVS) Surpasses Q3 Earnings and Revenue Estimates

CVS Health (CVS) Surpasses Q3 Earnings and Revenue Estimates

CVS Health (CVS) came out with quarterly earnings of $1.6 per share, beating the Zacks Consensus Estimate of $1.36 per share. This compares to earnings of $1.09 per share a year ago.

Zacks | 7 months ago
CVS books a $5.7 billion loss in its health-services business, tarnishing upbeat earnings

CVS books a $5.7 billion loss in its health-services business, tarnishing upbeat earnings

CVS Health's stock falls as a large charge to write off the value of an underperforming business takes the shine off an otherwise strong earnings report.

Marketwatch | 7 months ago
CVS Posts Loss on Write-Down, Boosts Guidance

CVS Posts Loss on Write-Down, Boosts Guidance

CVS Health raised its guidance for the rest of the year, boosted by improved performance at its Aetna insurance unit.

Wsj | 7 months ago
CVS raises full-year forecast, takes $5.7 billion impairment charge on health clinics

CVS raises full-year forecast, takes $5.7 billion impairment charge on health clinics

CVS Health raised its annual adjusted profit forecast on Wednesday, aided by improved pharmacy revenues, but also announced a $5.73 billion writedown of healthcare businesses including its in-pharmacy MinuteClinics.

Reuters | 7 months ago
CVS beats estimates, hikes guidance as insurance business improves

CVS beats estimates, hikes guidance as insurance business improves

CVS Health reported third-quarter earnings and revenue that blew past estimates and raised its adjusted profit outlook, as the company sees improvement in its insurance unit. The quarterly results cap David Joyner's first full year as CEO of the company, which struggled to drive higher profits and improve its stock performance under Karen Lynch.

Cnbc | 7 months ago
Is CVS Health's Pharmacy & Consumer Wellness Poised for a Stronger Q3?

Is CVS Health's Pharmacy & Consumer Wellness Poised for a Stronger Q3?

CVS' Pharmacy & Consumer Wellness arm gains traction from tech upgrades, new Rite Aid assets and its evolving CostVantage model.

Zacks | 7 months ago
CVS To Close 16 Oak Street Health Centers Amid Industry Cost Issues

CVS To Close 16 Oak Street Health Centers Amid Industry Cost Issues

CVS Health is shuttering 16 Oak Street Health Centers, or 7% of the total number of the senior-focused primary care locations the company operates across the U.S.

Forbes | 7 months ago
Loading...
Load More